A common standard for conflict of interest disclosure in addiction journals

Addiction

Volumn 104, Issue 11, 2009, Pages 1779-1784

  Goozner, Merrill ^a   Caplan, Arthur ^b   Moreno, Jonathan ^b   Kramer, Barnett S ^c   Babor, Thomas F ^d,f   Husser, Wendy C ^e  

^a Center for Science in the Public Interest   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^e AMERICAN COLLEGE OF SURGEONS   (United States)

^f UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Common standard; Conflict of interest; Corporate influences; Disclosure policies; Journal policies; Research integrity; Scientific journals

Indexed keywords

ALCOHOL;

ADDICTION; CONFLICT OF INTEREST; CONSULTATION; DRUG INDUSTRY; EDITOR; LAW ENFORCEMENT; PEER REVIEW; REVIEW; SCIENTIFIC LITERATURE; TOBACCO;

CONFLICT OF INTEREST; DISCLOSURE; EDITORIAL POLICIES; HUMANS; PEER REVIEW, RESEARCH; PERIODICALS AS TOPIC; RESEARCH SUPPORT AS TOPIC; SUBSTANCE-RELATED DISORDERS;

EID: 70349858058     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2009.02594.x     Document Type: Review

References (26)

1. Armstrong D. Amid suits over mold, experts wear two hats. Wall Street Journal, 9 January 2007.
2. Rowlan D. R. Medical group puts stop to talks on drug firm ties. Boston Globe, 27 December 2006.
3. Armstrong D. Financial ties to industry cloud major depression study. Wall Street Journal, 11 July 2006.
4. Abelson R. Charities tied to doctors get drug industry gifts. New York Times, 27 June 2006.
5. Read Y. T. Divided loyalties? Washington Post, 7 February 2006.
6. Check E. Journals scolded for slack disclosure rules. Nature, 18 January 2006.
7. Boyd E. A., Cho M. K., Bero L. A. Final conflict-of-interest policies in clinical research: issues for clinical investigators. Acad Med 2003 78 : 769 774.
8. Krimsky S., Rothenberg L. S. Conflict of interest policies in science and medical journals: editorial practices and author disclosures. Sci Eng Ethics 2001 7 : 205 218.
9. Flanagin A., Fontanarosa P. B., DeAngelis C. D. Update on JAMA's conflict of interest policy. JAMA 2006 296 : 220 221.
10. Graf C., Wager E., Bowman A., Fiack S., Scott-Lichter D., Robinson A. Best practice guidelines on publication ethics: a publisher's perspective. Int J Clin Pract 2007 61 : 1 26.
11. American Chemical Society. Ethical Guidelines to Publication of Chemical Research. January. Washington, DC, USA : American Chemical Society 2006. Available from http://pubs.acs.org/page/policy/ethics/index.html (accessed 17 September 2009).
12. Brockway L. M., Furcht L. T. Conflicts of interest in biomedical research - the FASEB guidelines. FASEB J 2006 20 : 2435 2438.
13. Relman A. S. Dealing with conflicts of interest. N Engl J Med 1984 310 : 1182 1183.
14. Bekelman J. E., Li Y., Gross C. Scope and impact of financial conflicts of interest in biomedical research. JAMA 2003 289 : 454 465 Review P. M., Torres J. Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000-2005. JAMA 2006 295 : 2270 2274.
15. Lesser L. I., Ebbeling C. B., Goozner M., Wypij D., Ludwig D. S. Relationship between funding source and conclusion among nutrition-related scientific articles. PLoS Med 2007 4 : e5. DOI: 10.1371/journal.pmed.0040005.
16. Fontanarosa P. B., Flanagin A., DeAngelis C. D. Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies. JAMA 2005 294 : 110 111.
17. Angell M., Kassirer J. P. Editorials and conflicts of interest. N Engl J Med 1996 335 : 1055 1056.
18. Drazen J. M., Curfman G. D. Financial associations of authors. N Engl J Med 2002 346 : 1901 1902.
19. Coyne D. Influence of industry on renal guideline development. Clin J Am Soc Nephrol 2007 2 : 3 7.
20. National Institutes of Health (NIH). Consensus Development Program. Available at: http://consensus.nih.gov/aboutCDP.htm (accessed 30 July 2009).
21. Jahiel R., Babor T. F. Industrial epidemics, public health advocacy and the alcohol industry: lessons from other fields. Addiction 2007 102 : 1335 1339.
22. Babor T. F. Alcohol research and the alcoholic beverage industry issues, concerns and conflicts of interest. Addiction 2009 104 : 34 47.
23. Hirschhorn N., Bialous S. A., Shatenstein, S. Philip Morris' new scientific initiative an analysis. Tob Control 2001 10 : 247 252.
24. Harris G. Cigarette company paid for lung cancer study. New York Times, 26 March 2008, p. A1.
25. Goozner M. Unrevealed: non-disclosure of conflicts of interest in four leading medical and scientific journals. Center for Science in the Public Interest. July 2004. Available at: http://www.cspinet.org/new/pdf/unrevealed- final.pdf (accessed 30 July 2009).
26. Goehl T. J. Embracing scrutiny. Environmental Health Perspectives, October 2004. Available at: http://www.ehponline.org/docs/2004/112-14/ EHP112pa788PDF.pdf (accessed 30 July 2009).